ENTBF (Entheon Biomedical) Institutional Ownership: 0.07% (As of Jul. 12, 2026)


What is Entheon Biomedical Institutional Ownership?

Entheon Biomedical ENTBF Institutional Ownership is 0.07% as of Jul. 12, 2026. The stock has 2 warning signs investors should review.

Institutional ownership is the percentage of shares that are owned by institutions out of the total shares outstanding. As of today, Entheon Biomedical's institutional ownership is 0.07%.

Insider Ownership is the percentage of shares that are owned by company insiders relative to the total shares outstanding. As of today, Entheon Biomedical's Insider Ownership is 0.00%.

Float Percentage Of Total Shares Outstanding is the percentage of float shares relative to the total shares outstanding. As of today, Entheon Biomedical's Float Percentage Of Total Shares Outstanding is 0.00%.

Entheon Biomedical Institutional Ownership Historical Data

* Premium members only.

The historical data trend for Entheon Biomedical's Institutional Ownership can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Entheon Biomedical Institutional Ownership Chart

Entheon Biomedical Historical Data

The historical data trend for Entheon Biomedical can be seen below:

2022-05-31 2022-06-30 2022-07-31 2022-08-31 2022-09-30 2022-10-31 2022-11-30 2022-12-31 2023-01-31 2023-02-28
Institutional Ownership 0.07 0.07 0.07 0.07 0.07 0.07 0.07 0.07 0.07 0.07

Entheon Biomedical Institutional Ownership Calculation

The percentage of shares that are owned by institutions out of the total shares outstanding.

What does a Institutional Ownership of 0.07% mean?
Entheon Biomedical (ENTBF) has a Institutional Ownership of 0.07% as of Jul. 12, 2026. Institutional ownership equals the percent of shares owned by financial institutions relative to total shares. View historical data on Entheon Biomedical and its competitors.
Is Entheon Biomedical's Institutional Ownership too high?
Entheon Biomedical's current Institutional Ownership is 0.07%.
How does Entheon Biomedical's Institutional Ownership compare to VRTX and REGN?
Entheon Biomedical's Institutional Ownership of 0.07% can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Institutional Ownership for a Biotechnology company?
A good Institutional Ownership depends on the Biotechnology industry context. However, Institutional Ownership should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Institutional Ownership mean?
A high Institutional Ownership can signal that a stock is expensive relative to its fundamentals. Institutional ownership equals the percent of shares owned by financial institutions relative to total shares. View historical data on Entheon Biomedical and its competitors. Entheon Biomedical's current Institutional Ownership is 0.07%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Entheon Biomedical stock overvalued right now?
Entheon Biomedical (ENTBF) has a current Institutional Ownership of 0.07%. The current Institutional Ownership is 0.07%. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Institutional Ownership calculated?
Institutional Ownership is calculated from a company's financial statements. For Entheon Biomedical (ENTBF), the current Institutional Ownership is 0.07% as of Jul. 12, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Entheon Biomedical Business Description

Other Exchanges 1XU:GermanyENBI.X:Canada
Address 999 West Broadway Street, Suite 720, Vancouver, BC, CAN, V5Z 1K5
Entheon Biomedical Corp is a biotechnology research and development company focused on treating addiction and substance use disorders.